EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patientsAccess, latest, Myeloma, NewsNovember 20, 2024
The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myelomaAccess, MyelomaAugust 30, 2022
The FDA approves belantamab mafodotin for relapsed or refractory myelomaAccess, MyelomaAugust 6, 2020
Watch the webinar “Importance of good nutrition and healthy diet for young myeloma patients”Myeloma, VideosOctober 18, 2024
During European Myeloma Day, MPE highlights the importance of improving access to clinical trialsAccess, MPE, MyelomaSeptember 27, 2024
EMA recommends a new indication for daratumumab in adult patients with newly diagnosed myeloma who are eligible for autologous stem cell transplantAccess, MyelomaSeptember 26, 2024
Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern EuropeAccess, MyelomaJune 25, 2023
